JP2007508270A - I.a.ジスリピデミアの治療におけるhppar作用物質として使用するためのチアゾール−2−カルボキシアミド誘導体 - Google Patents

I.a.ジスリピデミアの治療におけるhppar作用物質として使用するためのチアゾール−2−カルボキシアミド誘導体 Download PDF

Info

Publication number
JP2007508270A
JP2007508270A JP2006530145A JP2006530145A JP2007508270A JP 2007508270 A JP2007508270 A JP 2007508270A JP 2006530145 A JP2006530145 A JP 2006530145A JP 2006530145 A JP2006530145 A JP 2006530145A JP 2007508270 A JP2007508270 A JP 2007508270A
Authority
JP
Japan
Prior art keywords
acid
hppar
compounds
ppar
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006530145A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007508270A5 (cg-RX-API-DMAC7.html
Inventor
ジェリベール,フランソワーズ,ジャンヌ
マルトル,ポール
Original Assignee
スミスクライン ビーチャム コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン ビーチャム コーポレーション filed Critical スミスクライン ビーチャム コーポレーション
Publication of JP2007508270A publication Critical patent/JP2007508270A/ja
Publication of JP2007508270A5 publication Critical patent/JP2007508270A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP2006530145A 2003-10-09 2004-10-07 I.a.ジスリピデミアの治療におけるhppar作用物質として使用するためのチアゾール−2−カルボキシアミド誘導体 Pending JP2007508270A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0323702.1A GB0323702D0 (en) 2003-10-09 2003-10-09 Chemical compound
PCT/EP2004/011386 WO2005037804A1 (en) 2003-10-09 2004-10-07 Thiazole-2-carboxamide derivatives for use as hppar agonists in the treatment of i.a. dyslipidemia

Publications (2)

Publication Number Publication Date
JP2007508270A true JP2007508270A (ja) 2007-04-05
JP2007508270A5 JP2007508270A5 (cg-RX-API-DMAC7.html) 2007-06-28

Family

ID=29433611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006530145A Pending JP2007508270A (ja) 2003-10-09 2004-10-07 I.a.ジスリピデミアの治療におけるhppar作用物質として使用するためのチアゾール−2−カルボキシアミド誘導体

Country Status (7)

Country Link
US (1) US20070167628A1 (cg-RX-API-DMAC7.html)
EP (1) EP1680410A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007508270A (cg-RX-API-DMAC7.html)
AR (1) AR046058A1 (cg-RX-API-DMAC7.html)
GB (1) GB0323702D0 (cg-RX-API-DMAC7.html)
TW (1) TW200518748A (cg-RX-API-DMAC7.html)
WO (1) WO2005037804A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011163198A2 (en) * 2010-06-21 2011-12-29 Board Of Regents, The University Of Texas System Tg2 inhibitors and uses thereof
CN108486209B (zh) * 2018-03-22 2022-03-18 浙江工业大学 一种高通量快速筛选产(r)-2-(4-羟基苯氧基)丙酸菌株的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046232A1 (en) * 1998-03-10 1999-09-16 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives and drugs containing the same as the active ingredient
WO2002096895A1 (en) * 2001-05-31 2002-12-05 Glaxo Group Limited Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046232A1 (en) * 1998-03-10 1999-09-16 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives and drugs containing the same as the active ingredient
WO2002096895A1 (en) * 2001-05-31 2002-12-05 Glaxo Group Limited Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor

Also Published As

Publication number Publication date
US20070167628A1 (en) 2007-07-19
WO2005037804A1 (en) 2005-04-28
EP1680410A1 (en) 2006-07-19
GB0323702D0 (en) 2003-11-12
TW200518748A (en) 2005-06-16
AR046058A1 (es) 2005-11-23

Similar Documents

Publication Publication Date Title
JP3884290B2 (ja) Hpparアルファアクチベーターとしての置換オキサゾールおよびチアゾール誘導体
EP1392665B1 (en) Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
AU2002312954A1 (en) Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
JP2004517100A (ja) hPPARアルファアゴニストとしての置換オキサゾールおよびチアゾール
EP1399430B1 (en) Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
AU2002317765A1 (en) Oxazol/ thiazol-derivatives activators of the hPPAR-alpha receptor
US7141591B2 (en) 1,2,4-oxadiazole derivatives as hPPAR alpha agonists
AU2002220902A1 (en) 1, 2, 4-oxadiazole derivatives as hPPAR alpha agonists
US20070167628A1 (en) Thiazole-2-carboxamide derivatives for use as hippar agonists in the treatment of i.a. dyslipidemia
HK1064367B (en) Oxazol/thiazol-derivatives activators of the hppar-alpha receptor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070511

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070511

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101102

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110329